Postoperative Pain Control After Cesarean Section by Continuous Infusion Pump System Versus Ropivacaine Hydrogel: A Prospective Randomized Clinical Trial
Gels · 12.03.2026 · 12 (3) · 234
DOI: 10.3390/gels12030234 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Gels, online erschienen am 12.03.2026. Verfasst von Ji Eun Park und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Gyeongsang National University Changwon Hospital, Changwon 51472, Republic of Korea. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gyeongsang National University Hospital.
Themen: Schmerzmanagement
Abstract (Originalsprache)
Objective
The objective of this study was to evaluate the efficacy of a ropivacaine-loaded poloxamer 407 (P407)-based thermosensitive hydrogel applied at the subfascial site compared with a continuous local anesthetic delivery system using a catheter for postoperative pain control after cesarean section (CS), in combination with standard intravenous patient-controlled analgesia (IV-PCA).
Methods
This single-center, prospective randomized controlled trial included 72 pregnant women undergoing CS between April and October 2025. Participants were randomly assigned to receive either ropivacaine hydrogel or catheter-based ropivacaine infusion, both in conjunction with IV-PCA. Primary outcomes included numeric rating scale (NRS) pain scores at 3, 6, 12, 24, and 48 h postoperatively. Secondary outcomes included the time to first NSAID request and the cumulative use of rescue NSAIDs.
Results
There were no significant differences in baseline characteristics between the groups. NRS pain scores did not differ significantly at any time point, although they varied significantly over time within each group. The hydrogel group showed a statistically significant delay in the time to first NSAID request (6.3 ± 5.1 h vs. 5.0 ± 6.1 h, p = 0.049) and higher cumulative NSAID use (2.4 ± 1.7 vs. 1.6 ± 1.2, p = 0.035). No serious complications were observed in either group.
Conclusion
The ropivacaine hydrogel provided postoperative pain control comparable to that of the continuous catheter system, with no statistically significant differences in NRS scores observed between groups. Given its ease of use, absence of catheter-related concerns, and substantially lower total anesthetic dose, the P407-based hydrogel may represent a practical and patient-friendly alternative for post-cesarean analgesia.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Gyeongsang National University Changwon Hospital, Changwon 51472, Republic of Korea.
- Department of Obstetrics and Gynecology, Gyeongsang National University School of Medicine, Jinju 52727, Republic of Korea.
- Institute of Health Science, Gyeongsang National University, Jinju 52727, Republic of Korea.
ORCID-Profile: Ji Eun Park, Jong Chul Baek
Förderung
- Gyeongsang National University Hospital
Zitieren
APA
Park, J. E., Jo, H. C., Baek, J. C., & Yang, J. (2026). Postoperative Pain Control After Cesarean Section by Continuous Infusion Pump System Versus Ropivacaine Hydrogel: A Prospective Randomized Clinical Trial. Gels, 12(3), 234. https://doi.org/10.3390/gels12030234
Vancouver
Park JE, Jo HC, Baek JC, Yang J. Postoperative Pain Control After Cesarean Section by Continuous Infusion Pump System Versus Ropivacaine Hydrogel: A Prospective Randomized Clinical Trial. Gels. 2026;12(3):234. doi:10.3390/gels12030234
BibTeX
@article{Park2026,
author = {Park, Ji Eun and Jo, Hyen Chul and Baek, Jong Chul and Yang, Juseok},
title = {Postoperative Pain Control After Cesarean Section by Continuous Infusion Pump System Versus Ropivacaine Hydrogel: A Prospective Randomized Clinical Trial},
journal = {Gels},
year = {2026},
volume = {12},
number = {3},
pages = {234},
doi = {10.3390/gels12030234}
}
EUVIMED